Prioritizing drug targets for Alzheimer's Disease using a Mendelian Randomization framework integrating neuroimaging and genomics (2022)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/alz.069459
Publication URI: http://dx.doi.org/10.1002/alz.069459
Type: Journal Article/Review
Parent Publication: Alzheimer's & Dementia
Issue: S6